Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tarsus Pharmaceuticals
Biotech
Eyelid mites no match for Tarsus eye drop, teeing up FDA push
Tarsus says mites are no match for its novel eye drop, posting positive phase 3 data that will form an FDA regulatory filing later this year.
Max Bayer
May 2, 2022 11:10am
LianBio inks $325M IPO for pipeline with BMS, BridgeBio, Lyra
Nov 1, 2021 10:00am
Tarsus eyes FDA filing in 2022 for eyelid mange eye drop
Jun 21, 2021 6:05am
